Cargando…
Hybrid Nitric Oxide Donor and its Carrier for the Treatment of Peripheral Arterial Diseases
Nitric oxide (NO) has been known to promote physiological angiogenesis to treat peripheral arterial diseases (PAD) by increasing the vascular endothelial growth factor (VEGF) level in endothelial cells (ECs) and preventing platelet adherence and leukocyte chemotaxis. However, the ongoing ischemic ev...
Autores principales: | Le, Duong Q., Kuriakose, Aneetta E., Nguyen, Dat X., Nguyen, Kytai T., Acharya, Suchismita |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5562917/ https://www.ncbi.nlm.nih.gov/pubmed/28821752 http://dx.doi.org/10.1038/s41598-017-08441-9 |
Ejemplares similares
-
Novel Thiol Containing Hybrid Antioxidant-Nitric Oxide Donor Small Molecules for Treatment of Glaucoma
por: Amankwa, Charles E., et al.
Publicado: (2021) -
Scaffold-based lung tumor culture on porous PLGA microparticle substrates
por: Kuriakose, Aneetta E., et al.
Publicado: (2019) -
Engineering Delivery of Nonbiologics Using Poly(lactic-co-glycolic acid) Nanoparticles for Repair of Disrupted
Brain Endothelium
por: Inyang, Edidiong, et al.
Publicado: (2020) -
Characterization of Photoluminescent Polylactone-Based Nanoparticles for Their Applications in Cardiovascular Diseases
por: Kuriakose, Aneetta E., et al.
Publicado: (2019) -
Dual-Drug Containing Core-Shell Nanoparticles for Lung Cancer Therapy
por: Menon, Jyothi U., et al.
Publicado: (2017)